India's Lyka Labs climbs after regulatory body approves Pregabalin Gel

Lyka Labs

15/10/2024 05:11

** Shares of Lyka Labs Ltd  LYKA.NS  rise as much as 7.1% to
160 rupees
    ** The pharma co says the Central Drugs Standard Control
Organization of India (CDSCO) gave permission to Lyka Labs to
manufacture and market Pregabalin Gel 8% w/w for treatment of
diabetic neuropathic pain in India
    ** Stock on track to gain for a third straight day
    ** More than 200,000 shares traded, their busiest day yet in
a week
    ** LYKA stock up 6.3%, adds to YTD gains of 28.2% so far

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))